Comments to USP: Sodium Salicylate Proposed Monograph Share page: Docket Number: C132966 These comments are primarily focused on the use of Ultra-High Performance Liquid Chromatography as the method of choice for assay and organic impurities. Download Document Issues: Other Issues Quality Related Posts Press Releases and Statements CHPA Submits Official Comments on Section 232 National Security Investigation of Pharmaceuticals May 8, 2025 Articles Background: HHS, FDA and Food Additives and Artificial Colors Apr 30, 2025 Q&A for CHPA Members: The Impact of Tariffs on Consumer Healthcare Companies